Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InMed Pharmaceuticals (INM) Non Operating Income (2023 - 2024)

InMed Pharmaceuticals' Non Operating Income history spans 2 years, with the latest figure at $528120.0 for Q2 2024.

  • For Q2 2024, Non Operating Income rose 7.2% year-over-year to $528120.0; the TTM value through Jun 2024 reached $1.1 million, changed N/A, while the annual FY2024 figure was $527901.0, 7.2% up from the prior year.
  • Non Operating Income reached $528120.0 in Q2 2024 per INM's latest filing, up from $102987.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $528120.0 in Q2 2024 to a low of -$70.0 in Q1 2023.